Andere talen Eutilex.Co.,Ltd

Aandelen

A263050

KR7263050007

slotkoers Korea S.E. Andere beurzen 00:00:00 13-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2.030 ^KRW	+0,50%		-3,33%	-39,94%

16/05	Eutilex.Co.,Ltd rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
21/03	Eutilex.Co.,Ltd rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Eutilex.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
Eutilex.Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Eutilex.Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Eutilex.Co.,Ltd(KOSDAQ:A263050) dropped from S&P Global BMI Index	18-09-23
Eutilex.Co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14-08-23
Eutilex.Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Eutilex.Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23
Eutilex.Co.,Ltd. announced that it has received KRW 22.5003376 billion in funding	20-05-21
Eutilex.Co.,Ltd. announced that it expects to receive KRW 22.5003376 billion in funding	12-05-21
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA	27-01-21
Eutilex.Co.,Ltd. announced that it has received KRW 19.9998552 billion in funding from SUSUNG ASSET MANAGEMENT Co., Ltd., Asset One	30-10-20
Eutilex.Co.,Ltd. announced that it expects to receive KRW 19.9998552 billion in funding from SUSUNG ASSET MANAGEMENT Co., Ltd., Asset One	22-10-20
Eutilex Co.,Ltd. announced that it has received KRW 29 billion in funding	04-05-20
Eutilex Co.,Ltd. announced that it expects to receive KRW 29 billion in funding	24-04-20
CDMO business GenScript ProBio and Eutilex Co., Ltd. Enter into Exclusive Strategic Collaboration on Plasmid and Virus Process Development and Manufacturing for Car-T Programs	07-04-20
Eutilex Co.,Ltd.(KOSDAQ:A263050) added to S&P Global BMI Index	24-06-19
Eutilex Co.,Ltd.(KOSDAQ:A263050) added to S&P Global BMI Index	24-06-19
Eutilex Co.,Ltd.(KOSDAQ:A263050) added to S&P Global BMI Index	24-06-19
Eutilex Co.,Ltd. has completed an IPO in the amount of KRW 36.35 billion.	19-12-18
Eutilex Co.,Ltd. has filed an IPO.	18-09-18

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Eutilex.Co.,Ltd

Aandelen

A263050

KR7263050007

Andere talen

Filters